Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/25/14 → 03/24/16 |
Funding
- Gilead Sciences Incorporated: $15,441.28
A Phase 1 Double-Blind, Randomized, Placebo-controlled Multicenter Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects with Chronic Obstructive Pulmonary Disease
- Mammen, Manoj (PI)
- Gibbons, William (CoI)
Project: Research